
Global Health Ltd. share price
NSE: MEDANTA · Healthcare
₹1,433.60 -1.40%
Closing price data, updated 17 Nov 2026. 52-week range: -7.2% from high, +50.0% above low.
Price₹1,433.60
Market cap₹38,500 Cr
P/E62.3
P/B8.90
ROE15.2%
ROCE15.0%
Debt / equity0.30
Dividend yield0.00%
EPS₹23.03
Book value₹160.99
Operating margin16.8%
Dipscan score49 / 100
Share: WhatsAppX / TwitterTelegram
Global Health Ltd. shareholding pattern
As of Sep 2026: Promoters 33.00%, FIIs 9.91%, DIIs 17.01%, Government 0.00%, Public 5.40%, Others 34.68%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 33.00% | 33.00% | 33.01% | 33.01% | 33.01% | 33.01% |
| FIIs | 9.91% | 9.46% | 10.15% | 10.53% | 11.40% | 11.54% |
| DIIs | 17.01% | 16.89% | 14.76% | 14.00% | 12.98% | 12.20% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 5.40% | 5.60% | 5.88% | 5.95% | 6.03% | 6.48% |
| Others | 34.68% | 35.05% | 36.20% | 36.51% | 36.58% | 36.77% |
| No. of Shareholders | 135,371 | 140,531 | 147,390 | 151,241 | 155,806 | 156,372 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -1.40% | +3.32% | +12.00% | +1.64% | +18.29% | +22.23% |
Growth
| Sales growth, 3 years | +17.2% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +19.5% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +33.6% |
| Latest quarter profit vs last year | +39.3% |
Strengths and weaknesses
Strengths
- Company has delivered good profit growth of 80.7% CAGR over last 5 years
Weaknesses
- Stock is trading at 8.92 times its book value
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Global Health Ltd.?
Global Health Ltd. (MEDANTA) last closed at ₹1,433.60 (-1.40% on the day).
What is the market cap of Global Health Ltd.?
About ₹38,500 Cr.
What is the P/E ratio of Global Health Ltd.?
The price-to-earnings ratio is 62.3, and return on equity is 15.2%.
Figures are calculated from company results and exchange prices and are for information only.